
Overview
Wpd Pharmaceuticals is focused on developing biological and chemical molecules for targeted therapy aimed at treating brain glioma and other central nervous system cancers. The company is based in Warsaw, Poland.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $0 |
Filing timeliness
1 of 2 financial statements was filed late (for 2024, 9 days late). All were audited by a statutory auditor.
- 202515/06/2026
- 202424/07/2025
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Biotechnology testing
- Cancer drug development
- Targeted therapy molecules
Websites
- wpdpharmaceuticals.plWPD Pharmaceuticals - HomeGoogle AnalyticsGoogle Tag ManagerApache
Authorized Representatives
Manner of representation
The following person or persons are authorized to represent the company and to make declarations on its behalf with respect to the company's property and non-property rights and obligations: in the case of a one-person management board – the President of the Management Board independently; in the case of a multi-member management board – two members of the management board acting jointly or a member of the management board acting jointly with a commercial proxy.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2024-07-01.
07 1050 1298 1000 0090 8364 2224
46 1050 1298 1000 0090 3303 8465
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jul 14, 2026 | Merger registered | |
| Mar 27, 2026 | Merger registered |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Vasa Therapeutics sp. z o.o. | $363,111.30 | vasatherapeutics.com | ||
| Medicofarma Biotech S.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Globe Badania Kliniczne sp. z o.o. | $283,646.38 | globebadania.pl | ||
| Ti-Com sp. z o.o. | $157,549.77 | ticomglobal.com | ||
| Cogniguard sp. z o.o. | $97,667.64 | neuromedical.pl | ||
| Personather sp. z o.o. | $47,478.47 | personather.pl | ||
| Orphinic Scientific S.A. | $42,972.42 | orphinic.com | ||
| Biolabic sp. z o.o. | $37,688.85 | biolabic.pl | ||
| DR Joanna Sanford sp. k. | $28,674.82 | sanfordbiotech.com | ||
| Nanovelos S.A. | $24,842.03 | nanovelos.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-04-29 | Share capital increase (166,925.00 PLN → 183,425.00 PLN) | |
| 2025-08-21 | Share capital increase (151,904.70 PLN → 166,925.00 PLN) | |
| 2025-01-23 | Share capital increase (142,570.20 PLN → 151,904.70 PLN) | |
| 2024-09-02 | Share capital increase (123,827.10 PLN → 142,570.20 PLN) | |
| 2024-07-12 | Share capital increase (104,280.00 PLN → 123,827.10 PLN) |
FAQ
Last updated: 2026-10-22